Vivo Capital as of June 30, 2019
Portfolio Holdings for Vivo Capital
Vivo Capital holds 46 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 22.2 | $237M | 2.1M | 115.15 | |
| Crinetics Pharmaceuticals In (CRNX) | 7.9 | $84M | 3.4M | 25.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 6.9 | $73M | 2.8M | 26.50 | |
| Tricida | 5.3 | $56M | 1.4M | 39.46 | |
| Codexis (CDXS) | 4.5 | $48M | 2.6M | 18.43 | |
| Insmed (INSM) | 4.2 | $45M | 1.7M | 25.60 | |
| Iovance Biotherapeutics (IOVA) | 3.7 | $39M | 1.6M | 24.52 | |
| Sinovac Biotech (SVA) | 3.6 | $38M | 5.9M | 6.47 | |
| Zymeworks | 3.0 | $32M | 1.5M | 22.00 | |
| Kalvista Pharmaceuticals (KALV) | 2.8 | $30M | 1.4M | 22.15 | |
| Kadmon Hldgs | 2.4 | $26M | 13M | 2.06 | |
| Medicines Company | 2.3 | $24M | 669k | 36.47 | |
| Mirati Therapeutics | 2.2 | $24M | 233k | 103.00 | |
| Menlo Therapeutics | 2.2 | $24M | 4.0M | 5.99 | |
| Amyris | 2.2 | $23M | 6.5M | 3.56 | |
| Homology Medicines | 2.1 | $23M | 1.2M | 19.57 | |
| Eiger Biopharmaceuticals | 1.8 | $19M | 1.8M | 10.60 | |
| Orchard Therapeutics Plc ads | 1.7 | $18M | 1.3M | 13.99 | |
| Chiasma | 1.7 | $18M | 2.4M | 7.47 | |
| Cymabay Therapeutics | 1.4 | $15M | 2.2M | 7.16 | |
| Mei Pharma | 1.3 | $14M | 5.7M | 2.50 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $14M | 1.4M | 9.86 | |
| Aurinia Pharmaceuticals (AUPH) | 1.2 | $13M | 1.9M | 6.58 | |
| Soleno Therapeutics | 1.1 | $12M | 4.3M | 2.80 | |
| Rocket Pharmaceuticals (RCKT) | 1.1 | $12M | 787k | 15.00 | |
| Kiniksa Pharmaceuticals | 1.1 | $11M | 844k | 13.54 | |
| Obseva Sa | 1.0 | $11M | 937k | 11.31 | |
| Nabriva Therapeutics | 0.9 | $9.8M | 4.0M | 2.43 | |
| Apellis Pharmaceuticals (APLS) | 0.9 | $9.7M | 384k | 25.34 | |
| Verona Pharma Plc ads (VRNA) | 0.7 | $7.6M | 1.5M | 5.10 | |
| Galmed Pharmaceuticals | 0.7 | $7.1M | 971k | 7.35 | |
| Dermira | 0.6 | $6.7M | 700k | 9.56 | |
| Kala Pharmaceuticals | 0.6 | $6.7M | 1.0M | 6.38 | |
| Karuna Therapeutics Ord | 0.6 | $6.5M | 325k | 20.02 | |
| Matinas Biopharma Holdings, In (MTNB) | 0.6 | $5.9M | 6.8M | 0.86 | |
| Zogenix | 0.5 | $5.0M | 105k | 47.78 | |
| Precision Biosciences Ord | 0.3 | $3.7M | 281k | 13.25 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $3.6M | 1.6M | 2.19 | |
| Genocea Biosciences (GNCAQ) | 0.2 | $2.5M | 626k | 3.92 | |
| Agile Therapeutics | 0.2 | $2.2M | 1.5M | 1.46 | |
| Dbv Technologies S A | 0.2 | $2.2M | 270k | 8.22 | |
| Sierra Oncology | 0.1 | $1.4M | 2.4M | 0.56 | |
| Selecta Biosciences | 0.1 | $977k | 546k | 1.79 | |
| Akari Therapeutics | 0.1 | $699k | 346k | 2.02 | |
| Biopharmx Corp | 0.0 | $190k | 317k | 0.60 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $19k | 189k | 0.10 |
